Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza A
Public ClinicalTrials.gov record NCT03040141. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of IV VIS410 in Addition to Oseltamivir Compared With Oseltamivir Alone in Hospitalized Adults With Influenza A Infection Requiring Oxygen Support
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is to compare the efficacy and safety of VIS410 in combination with oseltamivir vs oseltamivir alone in severely ill subjects with influenza A infection requiring oxygen support.
Study identification
- NCT ID
- NCT03040141
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 89 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2, 2018
- Primary completion
- Nov 21, 2018
- Completion
- Nov 21, 2018
- Last update posted
- Dec 27, 2022
2018
United States locations
- U.S. sites
- 21
- U.S. states
- 14
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Visterra | Tucson | Arizona | 85724 | — |
| Visterra | Stanford | California | 94305 | — |
| Visterra | St. Petersburg | Florida | 33713 | — |
| Visterra | Atlanta | Georgia | 30342 | — |
| Visterra | Decatur | Georgia | 30033 | — |
| Visterra | Blackfoot | Idaho | 83221 | — |
| Visterra | Chicago | Illinois | 60637 | — |
| Visterra | Detroit | Michigan | 48202 | — |
| Visterra | Butte | Montana | 59701 | — |
| Visterra | Albany | New York | 12208 | — |
| Visterra | Syracuse | New York | 13210 | — |
| Visterra | Durham | North Carolina | 27710 | — |
| Visterra | Greensboro | North Carolina | 27403 | — |
| Visterra | Cleveland | Ohio | 44195 | — |
| Visterra | Columbus | Ohio | 43215 | — |
| Visterra | Allentown | Pennsylvania | 18103 | — |
| Visterra | Philadelphia | Pennsylvania | 19141 | — |
| Visterra | York | Pennsylvania | 17405 | — |
| Visterra | Roanoke | Virginia | 24014 | — |
| Visterra | Richland | Washington | 99352 | — |
| Visterra | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 93 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03040141, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 27, 2022 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03040141 live on ClinicalTrials.gov.